MeCP2 Deficiency in Neuroglia: New Progress in the Pathogenesis of Rett Syndrome
Rett syndrome (RTT) is an X-linked neurodevelopmental disease predominantly caused by mutations of the methyl-CpG-binding protein 2 (MeCP2) gene. Generally, RTT has been attributed to neuron-centric dysfunction. However, increasing evidence has shown that glial abnormalities are also involved in the...
Main Authors: | Xu-Rui Jin, Xing-Shu Chen, Lan Xiao |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2017-10-01
|
Series: | Frontiers in Molecular Neuroscience |
Subjects: | |
Online Access: | http://journal.frontiersin.org/article/10.3389/fnmol.2017.00316/full |
Similar Items
-
MeCP2_e2 partially compensates for lack of MeCP2_e1: A male case of Rett syndrome
by: Ryo Takeguchi, et al.
Published: (2020-02-01) -
MeCP2 modulates gene expression pathways in astrocytes
by: Yasui Dag H, et al.
Published: (2013-01-01) -
The Molecular Functions of MeCP2 in Rett Syndrome Pathology
by: Osman Sharifi, et al.
Published: (2021-04-01) -
Loss of MeCP2 function is associated with distinct gene expression changes in the striatum
by: Ying-Tao Zhao, et al.
Published: (2013-11-01) -
Rett-causing mutations reveal two domains critical for MeCP2 function and for toxicity in MECP2 duplication syndrome mice
by: Laura Dean Heckman, et al.
Published: (2014-06-01)